Stay updated on Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page’s footer version/release label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a site software update without changing the clinical trial information displayed.
    Difference
    0.0%
    Check dated 2026-04-25T05:22:12.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T03:48:05.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The site revision tag was updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-20T01:32:00.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T21:34:16.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    Primary peritoneal carcinoma was added to the listed conditions and a new Resources entry for the Genetic and Rare Diseases Information Center was included; the revision notes indicate a version update from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-12T02:29:06.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. This appears to be a minor backend/content management update with no changes to study content.
    Difference
    0.0%
    Check dated 2026-02-04T23:55:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial page.